The 2024 decline, and what we do not know about it

The numbers first, from the National Center for Health Statistics provisional counts, twelve months ending December, all reported as complete:

Year	Opioid-involved overdose deaths
2022	82,851
2023	80,719
2024	55,007
2025 (provisional)	45,008

That is a fall of about a third from the peak in two years, and roughly 46% by the provisional 2025 figure. In a field where every trend for two decades went the wrong way, this is genuinely remarkable.

The candidate explanations

• Naloxone saturation. Over-the-counter availability and mass distribution mean more overdoses are reversed. This would show up as fewer deaths without fewer overdoses.
• A change in the illicit supply. Composition, potency and adulterant mix shift constantly. A less lethal mix produces fewer deaths with no behavioral change at all.
• Treatment expansion. Wider access to buprenorphine and methadone, including telehealth initiation.
• A depleted susceptible population. The grimmest hypothesis: that the cohort at highest risk has been substantially reduced by the deaths of the preceding years. If this is a large part of the answer, the decline is not a policy success.
• Behavioral adaptation among people who use drugs — test strips, not using alone, smaller doses.

Did cutting opioid prescriptions cause the decline?

Probably not, even as a delayed effect. Prescription reduction had largely happened by 2019, and deaths rose for three years afterward. A four-to-seven-year lag with a large intervening rise is not a plausible causal shape.

Why does the cause of the decline matter?

Because the attribution determines what you keep funding. If it is naloxone, defunding naloxone because deaths are down would be self-defeating in the most direct way possible. If it is supply composition, none of the credit belongs to any program and the trend can reverse without warning. If it is treatment access, that is the thing to protect.

This is also a reason to insist on a comparison group in any evaluation. A program running from 2023 to 2025 that reports falling overdose deaths in its population has reported the national trend. See pilot design.

More: after the 2016 guideline · what population trends can tell you.

Frequently asked questions

Why are overdose deaths falling in America?

No single cause is proven. The leading candidates are wider naloxone access that reverses more overdoses, a change in the illicit supply toward a less lethal mix, expanded treatment with buprenorphine and methadone, behavioral changes such as test strips and not using alone, and a depleted high-risk population. Each would point funding in a different direction, so the answer matters.

What is the current state of the opioid crisis in America?

Opioid-involved overdose deaths peaked at 82,851 in 2022 and were 80,719 in 2023. They fell to 55,007 in 2024, about a third below the peak, and to a provisional 45,008 in 2025, roughly 46% below it. After two decades in which every trend went the wrong way, this is genuinely remarkable, and nobody can yet fully explain it.

Does naloxone explain the drop in overdose deaths?

It may be part of it. Over-the-counter naloxone and mass distribution mean more overdoses are reversed, which would show up as fewer deaths without fewer overdoses. But naloxone is one of several candidate explanations, and none has been proven. If naloxone is a large part of the answer, defunding it because deaths are down would be self-defeating in the most direct way possible.